Genoray Co

Genoray Co EBITDA per Share

The EBITDA per Share of Genoray Co (122310.KQ) as of Nov 3, 2026 is -16.48 KRW. In the previous year, EBITDA per Share was -208.64 KRW — a change of -92.10% (higher).

EBITDA per Share

-16.48KRW

YoY

-92.10%

Last updated:

EBITDA per Share of Genoray Co is 2025 -16.48 KRW. EBITDA per Share of Genoray Co was 2024 -208.64 KRW. It decreases by -92.10% higher compared to the previous year.

The Genoray Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
851.77 KRW
Jan 1, 2019
1,127.16 KRW
Jan 1, 2020
887.97 KRW
Jan 1, 2021
1,156.53 KRW
Jan 1, 2022
1,176.60 KRW
Jan 1, 2023
1,030.85 KRW
Jan 1, 2024
-208.64 KRW
Jan 1, 2025
-16.48 KRW
The Genoray Co EBITDA per Share history
YEAREBITDA per ShareYoY
-16.48KRW-92.10%
-208.64KRW-120.24%
1,030.85KRW-12.39%
1,176.60KRW+1.73%
1,156.53KRW+30.24%
887.97KRW-21.22%
1,127.16KRW+32.33%
851.77KRW+62.38%
524.56KRW+33.05%
394.25KRW+54.09%
255.86KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genoray Co Stock analysis

What does Genoray Co do? Genoray Co Ltd, based in Seongnam, South Korea, operates in the Health Care sector, specializing in medical and dental digital x-radiation systems. The company, listed on 28 May 2018, serves through two segments: Medical, focusing on mobile C-arm and mammography equipment, and Dental, offering panoramic, cephalometry, 3D CT, and portable X-ray solutions. Genoray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genoray Co stock

EBITDA per Share of Genoray Co is -16.48 KRW in 2025.

EBITDA per Share of Genoray Co changed from -208.64 KRW to -16.48 KRW, representing a -92.10% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Genoray Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Genoray Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genoray Co